Table 3.
Isolated bacteria | n (%)
|
P-value | |||
---|---|---|---|---|---|
Control (n=58) | Mild (n=8) | Moderate (n=55) | Severe (n=19) | ||
None | 31 (53.4%) | 3 (37.5%) | 23 (41.8%) | 2 (10.5%)#,¶ | 0.012* |
Staphylococcus (G+) | 23 (39.7%) | 5 (62.5%) | 29 (52.7%) | 12 (63.2%) | 0.218 |
S. epidermidis | 23 (39.7%) | 5 (62.5%) | 28 (50.9%) | 11 (57.9%) | 0.358 |
S. capitis | 2 (3.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0.412 |
S. aureus | 0 (0%) | 0 (0%) | 3 (5.5%) | 3 (15.8%)# | 0.026 |
S. hominis | 0 (0%) | 0 (0%) | 3 (5.5%) | 0 (0%) | 0.192 |
S. warneri | 0 (0%) | 0 (0%) | 0 (0%) | 1 (5.3%) | 0.093 |
Lysinibacillus (G+) | 0 (0%) | 1 (12.5%)#,¶ | 0 (0%) | 0 (0%) | 0.001* |
Microbacteriaceae (G+) | 6 (10.3%) | 0 (0%) | 8 (14.5%) | 3 (15.8%) | 0.611 |
Micrococcaceae | 3 (5.2%) | 0 (0%) | 5 (9.1%) | 2 (10.5%) | 0.660 |
Micrococcus luteus | 1 (1.7%) | 0 (0%) | 2 (3.6%) | 1 (5.3%) | 0.796 |
Microbacterium | 2 (3.4%) | 0 (0%) | 1 (1.8%) | 1 (5.3%) | 0.821 |
Bacillus (G+) | 1 (1.7%) | 0 (0%) | 2 (3.6%) | 1 (5.3%) | 0.796 |
B. circulans | 0 (0%) | 0 (0%) | 1 (1.8%) | 0 (0%) | 0.669 |
B. thermoamylovorans | 0 (0%) | 0 (0%) | 1 (1.8%) | 0 (0%) | 0.669 |
B. cereus | 1 (1.7%) | 0 (0%) | 0 (0%) | 1 (5.3%) | 0.402 |
Moraxella osloensis (G−) | 0 (0%) | 0 (0%) | 3 (5.5%) | 0 (0%) | 0.192 |
Xanthomonadaceae (G−) | 0 (0%) | 0 (0%) | 1 (1.8%) | 0 (0%) | 0.669 |
Corynebacterium (G+) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (31.6%)#,¶ | <0.001* |
C. macginleyi | 0 (0%) | 0 (0%) | 0 (0%) | 5 (26.3%)#,¶ | <0.001* |
C. pseudodiphtheriticum | 0 (0%) | 0 (0%) | 0 (0%) | 1 (5.3%) | 0.093 |
Paenibacillus (G+) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (5.3%) | 0.093 |
Notes: n (%): number of patients (percentage in the group of MGD severity). G+ and G− represent the Gram positive and negative bacteria, respectively.
P<0.05;
P<0.05 compared to control;
P<0.05 compared to mild;
P<0.05 compared to moderate.
Abbreviation: MGD, Meibomian gland dysfunction.